We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Arl3.0
Argireline Research
Too few graded studies
8 peer-reviewed studies
What the evidence says
Too few graded studies
Argireline doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from medium-quality randomised trials published 2002–2025.
Based on 8 studies · 3 RCTs
Confidence
Moderate confidence
By outcome
Skin healthModest reduction in the appearance of expression lines (cosmetic, not a health outcome) · 4-8 weeks
Too few graded studies5 studies
Steady research
2 studies in the last 5 years
200220132025
1Review2025
In plain English: Despite promising cosmetic outcomes, AH-8's low skin penetration limits its bioavailability and therapeutic potential.
Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. · International journal of molecular sciences (2025)
However, the precise biological mechanisms underlying these effects-particularly the peptide's ability to inhibit muscle contraction when applied topically-remain incompletely understood.
In some studies, AH-8 has also shown beneficial effects in scar remodeling and sebum regulation.
Despite promising cosmetic outcomes, AH-8's low skin penetration limits its bioavailability and therapeutic potential.
In plain English: Topical cosmeceuticals like botanicals, peptides and hydroquinone can effectively treat photodamaged skin.
Chan LKW, Lee KWA, Lee CH, Lam KWP, Lee KFV, Wu R, Wan J, Shivananjappa S, Sky WTH, Choi H, Yi KH. · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2024)
Results Most of the evidence behind cosmeceuticals is of high-quality ranging from Level I to Level II.
In particular, the evidence base behind peptides is the strongest with most studies achieving Level Ib status in the evidence hierarchy.
Conclusion Topical cosmeceuticals like botanicals, peptides and hydroquinone can effectively treat photodamaged skin.
In plain English: Our results confirm the antiwrinkle activity of acetyl hexapeptide-3. A significant decrease in TEWL with acetyl hexapeptide-3 treatment is observed.
Raikou V, Varvaresou A, Panderi I, Papageorgiou E. · J Cosmet Dermatol (2017)
Prospective, randomized controlled cosmetic-science study in 24 volunteers comparing acetyl hexapeptide-3, tripeptide-10-citrulline, their combination, and neither, over 60 days
In plain English: the significant cytotoxicity of argireline solution was observed under 18 to 10 000 fold higher concentrations (depending on cells that were examined) in comparison to doxorubicin.
Grosicki M, Latacz G, Szopa A, Cukier A, Kieć-Kononowicz K. · Acta Biochim Pol (2014)
Independent in-vitro cytotoxicity study across HEK-293, IMR-32 neuroblastoma, and human primary skin fibroblasts
Anti-proliferative effects were dose-dependent but appeared only at 18- to 10,000-fold higher concentrations than the reference cytotoxin doxorubicin
Supports a wide topical safety margin for cosmetic-use concentrations
7In VitroCited 93×2002
In plain English: skin topography analysis of an oil/water (O/W) emulsion containing 10% of the hexapeptide on healthy women volunteers reduced wrinkle depth up to 30% upon 30 days treatment.
Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. · Int J Cosmet Sci (2002)
Foundational design paper: the hexapeptide Ac-EEMQRR-NH2 ('Argireline') was rationally designed to mimic the cosmetic action of botulinum toxin non-toxically
A 10% O/W emulsion reduced wrinkle depth up to ~30% over 30 days in a small, uncontrolled cohort of healthy women — an appearance measure, not a controlled trial
Mechanistically, the peptide inhibited neurotransmitter release with potency similar to BoNT-A but much lower efficacy, by interfering with SNARE-complex formation/stability
In plain English: A review of the physiological basis and mechanism of action of acetyl hexapeptide-8 (Argireline), which also prepared two formulations: an emulsion with an external aqueous phase for normal-to-dry skin, and a gel for oily skin.